Apersy provide expert advisory services for Commercial Strategy and Market Access to integrate the commercial point of view throughout the... View Article
Author Archives for Adeline Chauvigné
New member | Apersy
26 April 2024Apersy provide expert advisory services for Commercial Strategy and Market Access to integrate the commercial point of view throughout the... View Article
Apax Partners acquires a majority stake in Porsolt
Apax Partners, a leading European private equity firm,announced that it has acquired a majority stake in Porsolt, an internationally recognized... View Article
Apax Partners acquires a majority stake in Porsolt
26 April 2024Apax Partners, a leading European private equity firm,announced that it has acquired a majority stake in Porsolt, an internationally recognized... View Article
New member | HC NEXT
Are you having trouble meeting your deadlines or your budget? Trouble to prioritize your project portfolio? Are you looking to... View Article
New member | HC NEXT
26 April 2024Are you having trouble meeting your deadlines or your budget? Trouble to prioritize your project portfolio? Are you looking to... View Article
New member | Patriarche
Patriarche. Augmented Architecture is a cross-disciplinary architecture group focusing on innovation (500 employees – 10 offices) Patriarche has extensive expertise... View Article
New member | Patriarche
26 April 2024Patriarche. Augmented Architecture is a cross-disciplinary architecture group focusing on innovation (500 employees – 10 offices) Patriarche has extensive expertise... View Article
BioMAdvanced Diagnostics received €900k in funding from Bpifrance
🧪 The “Aide au Développement Deeptech (ADD)” Grant is reserved for startups which develop highly technological innovations. So for BioMAdvanced... View Article
BioMAdvanced Diagnostics received €900k in funding from Bpifrance
26 April 2024🧪 The “Aide au Développement Deeptech (ADD)” Grant is reserved for startups which develop highly technological innovations. So for BioMAdvanced... View Article
New member | YouCie
After an overview of the mechanisms of the pharmacy and the problems encountered by the pharmacist and the patient, YouCie... View Article
New member | YouCie
26 April 2024After an overview of the mechanisms of the pharmacy and the problems encountered by the pharmacist and the patient, YouCie... View Article
New member | Abcely
Abcely’s mission is to develop new innovative medical and pharmaceutical technologies in the field of the treatment of mucosal cancers,... View Article
New member | Abcely
26 April 2024Abcely’s mission is to develop new innovative medical and pharmaceutical technologies in the field of the treatment of mucosal cancers,... View Article
XENOTHERA announces the efficacy of its XAV-19 antibody against the BQ.1.1 variant
In the context of a major resurgence of the COVID epidemic, the French biotech XENOTHERA has just carried out an... View Article
XENOTHERA announces the efficacy of its XAV-19 antibody against the BQ.1.1 variant
26 April 2024In the context of a major resurgence of the COVID epidemic, the French biotech XENOTHERA has just carried out an... View Article
Naobios signs a Research License Agreement with Valneva on EB66® cell line
Naobios announced the signature of a Research License Agreement with Valneva to assess the EB66® cell line as cell substrate for the evaluation... View Article
Naobios signs a Research License Agreement with Valneva on EB66® cell line
26 April 2024Naobios announced the signature of a Research License Agreement with Valneva to assess the EB66® cell line as cell substrate for the evaluation... View Article
OSE Immunotherapeutics receives €10 Million
This financing will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in therapeutic areas with... View Article
OSE Immunotherapeutics receives €10 Million
26 April 2024This financing will further support the progress and expansion of OSE Immunotherapeutics’ lead clinical development programs in therapeutic areas with... View Article